Skip to main content
Top
Published in: Pediatric Rheumatology 1/2020

Open Access 01-12-2020 | Mononucleosis | Case Report

Kawasaki disease with a concomitant primary Epstein - Barr virus infection

Authors: Nataly Rosenfeld, Diana Tasher, Adi Ovadia, Shirly Abiri, Ilan Dalal

Published in: Pediatric Rheumatology | Issue 1/2020

Login to get access

Abstract

Background

Kwasaki disease (KD) is the leading cause of acquired heart disease in children in most developed countries. The cause of KD remains unknown. The presumed theory is that KD occurs due to one or more infectious agents who evoke an abnormal immunological response in susceptible individuals. Epstein - Barr virus (EBV) infection has been considered as a suspected causative agent because of the potential effect on the immune system.

Case presentation

A previously healthy 19 month old boy presented with a 6 day history of fever accompanied by a diffuse macular erythematous rash that appeared 1 day after. The physical examination on admission revealed bilateral non-suppurative conjunctivitis, dry fissured and injected lips without “strawberry” tongue, diffuse macular rash on the trunk, face and limbs, swelling of the hands and feet, and right cervical lymphadenopathy (2 cm in diameter). Following fulfillment of all the clinical criteria, the diagnosis of KD was made and treatment with IVIG 2 g/Kg was administered along with oral aspirin (80 mg/ kg/day). However, despite the treatment, he remained febrile for an additional 2 days with persistent clinical manifestations. Therefore, he received a second 2 g/kg IVIG course with a favorable response. On the 14th day of illness the patient became febrile again and was readmitted. Blood examinations revealed remarkable leukocytosis up to 35.7 X 109/L with 87.3% lymphocytes and the blood smear revealed atypical lymphocytes and monocytes. The liver enzymes were elevated. The serology for infectious mononucleosis from his first admission revealed: IgM CMV (+), IgG CMV (−); IgM VCA EBV (+) IgG VCA EBV (−), IgG EBNA (−). To confirm infectious mononucleosis following the administration of 2 doses of IVIG, serum EBV PCR was performed and was positive (1.6X 103 cp/ml).

Conclusions

We describe here a case of KD with a concomitant primary EBV infection. To the best of our knowledge, this is the first case in western country that describes KD with acute EBV infection as confirmed by PCR. The case we described stands as a contribution in favor of the possible role of EBV in the development of KD.
Literature
1.
go back to reference Stanford T. Shulman. Intravenous immunoglobulin for the treatment of Kawasaki disease. Pediatr Ann. 2017;46(1):e25–8.CrossRef Stanford T. Shulman. Intravenous immunoglobulin for the treatment of Kawasaki disease. Pediatr Ann. 2017;46(1):e25–8.CrossRef
2.
go back to reference Rae S. M Yeung. Pathogenesis and treatment of Kawasaki's disease. Curr Opin Rheumatol. 2005;17:617–23.CrossRef Rae S. M Yeung. Pathogenesis and treatment of Kawasaki's disease. Curr Opin Rheumatol. 2005;17:617–23.CrossRef
3.
go back to reference David B, Anthony H. Kawasaki disease: what is the epidemiology telling us about the etiology? IJID. 2005;9:185–94. David B, Anthony H. Kawasaki disease: what is the epidemiology telling us about the etiology? IJID. 2005;9:185–94.
4.
go back to reference Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol. 1995;155(10):5018–21.PubMed Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol. 1995;155(10):5018–21.PubMed
5.
go back to reference Brown TJ, Crawford SE, Cornwall ML, et al. CD8 lymphocytes and macrophage infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184:940–3.CrossRef Brown TJ, Crawford SE, Cornwall ML, et al. CD8 lymphocytes and macrophage infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184:940–3.CrossRef
6.
go back to reference Kikuta H, Matsumoto S, Osato T. Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn. 1991;33(6):765–70.CrossRef Kikuta H, Matsumoto S, Osato T. Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn. 1991;33(6):765–70.CrossRef
7.
go back to reference Kikuta H, Nakanishi M, Ishikawa N, Konno M, Matsumoto S. Detection of Epstein - Barr virus sequences in patients with Kawasaki disease by means of polymerase chain reaction. Intervirology. 1992;33:1–5.PubMed Kikuta H, Nakanishi M, Ishikawa N, Konno M, Matsumoto S. Detection of Epstein - Barr virus sequences in patients with Kawasaki disease by means of polymerase chain reaction. Intervirology. 1992;33:1–5.PubMed
8.
go back to reference Shigeto F, Emiko F, Toshihiko M, Tomoyuki H, Yuki K, Maiko M. Children with Kawasaki disease are not infected with Epstein-Barr virus. Pediatr Infect Dis J. 2010;29(3):286–7.CrossRef Shigeto F, Emiko F, Toshihiko M, Tomoyuki H, Yuki K, Maiko M. Children with Kawasaki disease are not infected with Epstein-Barr virus. Pediatr Infect Dis J. 2010;29(3):286–7.CrossRef
9.
go back to reference Okano M, Hase N, Sakiyama Y, Matsumoto S. Long term observation in patients with Kawasaki syndrome and their relation to Epstein-Barr virus infection. Pediatr Infect Dis J. 1990;9:139–41.CrossRef Okano M, Hase N, Sakiyama Y, Matsumoto S. Long term observation in patients with Kawasaki syndrome and their relation to Epstein-Barr virus infection. Pediatr Infect Dis J. 1990;9:139–41.CrossRef
10.
go back to reference Landry ML. Immunoglobulin M for acute infection: True or False? Clin Vaccine Immunol. 2016;23:540–5.CrossRef Landry ML. Immunoglobulin M for acute infection: True or False? Clin Vaccine Immunol. 2016;23:540–5.CrossRef
Metadata
Title
Kawasaki disease with a concomitant primary Epstein - Barr virus infection
Authors
Nataly Rosenfeld
Diana Tasher
Adi Ovadia
Shirly Abiri
Ilan Dalal
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2020
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-00459-0

Other articles of this Issue 1/2020

Pediatric Rheumatology 1/2020 Go to the issue